↓ Skip to main content

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

Overview of attention for article published in Frontiers in Genetics, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
11 X users
patent
1 patent

Readers on

mendeley
144 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Published in
Frontiers in Genetics, September 2020
DOI 10.3389/fgene.2020.578011
Pubmed ID
Authors

Lourdes Hontecillas-Prieto, Rocío Flores-Campos, Andrew Silver, Enrique de Álava, Nabil Hajji, Daniel J. García-Domínguez

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 144 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 36 25%
Researcher 12 8%
Student > Bachelor 11 8%
Student > Master 10 7%
Student > Doctoral Student 6 4%
Other 15 10%
Unknown 54 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 35 24%
Pharmacology, Toxicology and Pharmaceutical Science 16 11%
Chemistry 14 10%
Medicine and Dentistry 8 6%
Agricultural and Biological Sciences 5 3%
Other 8 6%
Unknown 58 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2022.
All research outputs
#3,378,713
of 25,773,273 outputs
Outputs from Frontiers in Genetics
#914
of 13,789 outputs
Outputs of similar age
#84,131
of 427,508 outputs
Outputs of similar age from Frontiers in Genetics
#38
of 459 outputs
Altmetric has tracked 25,773,273 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,789 research outputs from this source. They receive a mean Attention Score of 3.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 459 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.